Researchers found that semaglutide, the active ingredient in the weight loss medications Ozempic and Wegovy, can lead to significant weight loss in adults over 65. In a recent analysis of several clinical trials, older adults taking this medication lost an average of 15.4% of their body weight, which is much more than the 5.1% lost by those taking a placebo. Many participants also experienced improvements in their heart health and metabolic markers, moving out of obesity categories entirely and achieving healthier weight levels.

This finding is especially important for older adults who want to maintain their health and quality of life as they age. Excess weight in this age group is linked to a range of health issues, including heart disease and diabetes. The study included 358 participants aged 65 and older, and the results indicate that semaglutide not only helps with weight loss but also improves factors like blood pressure and cholesterol levels, which are crucial for overall health.

The research analyzed data from multiple STEP trials, focusing on adults with obesity who did not have diabetes. While the results are promising, they come from a controlled clinical setting, meaning further studies are needed to confirm these benefits in broader populations. Additionally, while the overall safety profile of semaglutide was similar to that of the placebo, some participants reported more serious side effects.

If you’re considering weight loss options, it may be worth discussing semaglutide with your healthcare provider, especially if you are over 65 and struggling with obesity. Remember that any medication should be part of a comprehensive approach that includes lifestyle changes like diet and exercise.

Source: sciencedaily.com